Skip to content

Retrospective Study of 110 Cases of Uterine Rupture to Determine Obstetric and Neonatal Complications

Retrospective Study of 110 Cases of Uterine Rupture to Determine Obstetric and Neonatal Complications

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03052686
Acronym
RUVO
Enrollment
110
Registered
2017-02-14
Start date
2000-01-01
Completion date
2013-12-01
Last updated
2026-06-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anomaly Uterus

Keywords

Uterine rupture

Brief summary

This study has for objective to collect medical data from patients with uterine rupture at the childbirth.

Detailed description

This is a retrospective study, gathering data of five maternity in the department of Val d'Oise in France, during 13 years (between 01/01/2000 an 31/12/2013). The incidence of uterine rupture increases with increasing cesarean rates. It occurs at a rate of 0.08% across all childbirths in France, and 0.5 to 1% of the childbirths on cicatricial uterus in France. Although the risk factors are known, it is usually unexpected. This is a serious complication for the mother (mortality \<1%, severe morbidity at 15% ) and for the child (mortality for 3 to 6 % for childbirth at term, neonatal asphyxia for 6 to 15%) that can occur during pregnancy or during labor.

Interventions

OTHERChildbirth with uterine rupture

No intervention. Follow-up of women with rupture uterine at the childbirth.

Sponsors

Hôpital NOVO
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Childbirth with uterine rupture

Exclusion criteria

* Childbirth in a maternity which do not participate to the study

Design outcomes

Primary

MeasureTime frame
Identify maternal and foetal risk factors associated to an uterine rupture ; by the report of events during pregnancy, pathology, lifestyle, Concomitant pathology...1 day

Secondary

MeasureTime frame
Number of maternal and foetal adverse events associated to an uterine rupture at the childbirth.1 day

Countries

France

Contacts

PRINCIPAL_INVESTIGATORMARKOU Georges, PH

CH Rene Dubos, Pontoise

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 10, 2026